News & Trends - Pharmaceuticals
First study to show alcohol and tobacco policies reduced cancer deaths in Australia
Policies aimed at cutting alcohol and tobacco consumption, including the introduction of random breath testing programs and bans on cigarette advertising, have resulted in a significant reduction in Australian cancer death rates, new research shows.
The La Trobe Centre for Alcohol Policy Research (CAPR) has led the first study into how public health policies on alcohol and tobacco implemented from the 1960s affected cancer deaths in Australia.
Researchers led by La Trobe epidemiologist Dr Jason (Heng) Jiang compared cancer mortality data available from the 1950s with historical alcohol and tobacco control policies and 100-years of consumption data.
Dr Jiang said the results are a century in the making.
“Our research provides new evidence that key public health policies on alcohol and tobacco introduced in Australia from the 1960s to 2013 are related to reductions in mortality rates for various cancers,” Dr Jiang said.
“The changes in mortality rates are measured over 20-year periods and emphasise that the effects of alcohol and tobacco policies cannot be fully evaluated in the short-term.
“It’s clear from our findings that the full effect of more recent policies, such as plain cigarette packaging and alcohol content labelling of beverages, may not be known for decades.”
Enhance visibility and amplify your company’s brand value to Pharma, MedTech and Biotech subscribers. Contact us.
Published today in BMC Medicine, the researchers found:
• A series of key health policies on alcohol and tobacco have prevented more than 5 per cent (36,000) of total cancer deaths in Australia between the 1960s and 2013
• The introduction of random breath testing programs in Australia in 1976 was associated with a reduction in population drinking and cancer death rates for both men and women. The policy prevented 1 per cent of male deaths (4880) and 0.8 per cent of female deaths (1680) overall between the 1980s and 2013
• The release of UK and US public health reports in 1962 and 1964 on the health effects of tobacco was associated with a reduction in Australian tobacco consumption and cancer death rates – excluding liver cancer – with 3 per cent of male (13,400) and 4 per cent of female cancer deaths (11,600) in Australia in the last 30 years
• The ban on cigarette advertising on Australian TV and radio in 1976 was associated with a 1.9 (4,520) and 2.2 (2,430) per cent reduction in total male and female cancer death rates respectively, excluding liver cancer, between the 1980s and 2013
• Liquor license liberalisation introduced in the 1960s was linked to an increase of 0.6 per cent (2,680) of total male cancer deaths in the last 30 years
Dr Jiang said the study should help inform future government campaigns or policies on alcohol and tobacco.
“It’s important to evaluate what works, what doesn’t, and where to invest future funding,” Dr Jiang said.
“We hope these findings will also help Australians make more informed decisions on their alcohol and tobacco consumption.”
Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
Digital & Innovation
Cybersecurity tops investment priorities for ANZ companies
Digital & Innovation: Cybersecurity remains the top technology investment for Australian and New Zealand (ANZ) companies, with a striking 88% […]
MoreNews & Trends - Pharmaceuticals
Novo Nordisk and Lilly’s GLP-1 agonists show promise in type 1 diabetes
Pharma News: GLP-1 receptor agonists lead to significant weight loss and improve blood sugar control in individuals with type 1 […]
MoreNews & Trends - MedTech & Diagnostics
Health Department’s proposed reporting rules face industry pushback over costs and confidentiality
MedTech News: The Department of Health has unveiled stakeholder feedback on the reporting requirements for the Prescribed List (PL), sparking […]
MoreNews & Trends - MedTech & Diagnostics
Threat to innovation: Health Department’s PL reforms spark industry backlash
MedTech News: The Department of Health has unveiled stakeholder feedback on the alignment of charges for supplying medical devices with […]
More